NCT05558605 Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
| NCT ID | NCT05558605 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baker Heart and Diabetes Institute |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 612 participants |
| Start Date | 2023-02-24 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 612 participants in total. It began in 2023-02-24 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.
Eligibility Criteria
Inclusion Criteria: * Age \>45 years * eligible for Medicare * exercise intolerance or cardiovascular (CV) risk factors Exclusion Criteria: * Known HF or HVD * situations where cardio-protection is already indicated (eg. known CAD) * comorbid conditions with life expectancy \<2 years * inability to provide written informed consent
Contact & Investigator
Tom Marwick, MBBS, PhD
PRINCIPAL INVESTIGATOR
Baker Heart and Diabetes Institute
Frequently Asked Questions
Who can join the NCT05558605 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05558605 currently recruiting?
Yes, NCT05558605 is actively recruiting participants. Contact the research team at tom.marwick@baker.edu.au for enrollment information.
Where is the NCT05558605 trial being conducted?
This trial is being conducted at Alice Springs, Australia.
Who is sponsoring the NCT05558605 clinical trial?
NCT05558605 is sponsored by Baker Heart and Diabetes Institute. The principal investigator is Tom Marwick, MBBS, PhD at Baker Heart and Diabetes Institute. The trial plans to enroll 612 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.